World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
57327
World Ranking
4877
National Ranking
2641

Michael R. Jaff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael R. Jaff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 565 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael R. Jaff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Jaff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael R. Jaff is affiliated with Boston Scientific in the United States and has a research portfolio primarily focused on medicine with significant contributions to surgery, pulmonary and respiratory medicine, internal medicine, epidemiology, and cardiology and cardiovascular medicine.

The main topics covered in their work include:

  • Peripheral Artery Disease Management
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Procedures and Complications
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Diagnosis and Treatment of Venous Diseases
  • Coronary Interventions and Diagnostics

Frequent publication venues for Michael R. Jaff include:

  • Circulation
  • Journal of Vascular Surgery
  • Journal of Vascular and Interventional Radiology
  • Journal of Endovascular Therapy
  • JACC: Cardiovascular Interventions

They have collaborated regularly with several co-authors, notably:

  • Eric A. Secemsky
  • Kenneth Rosenfield
  • Sahil A. Parikh
  • Jay Giri
  • Ido Weinberg

Selected recent papers authored by Michael R. Jaff include:

  • American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism (2020), published in Blood Advances
  • Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (2022), published in New England Journal of Medicine
  • Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study (2022), published in American Heart Journal
  • Mortality and Paclitaxel-Coated Devices (2020), published in Circulation
  • Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort (2020), published in Journal of Endovascular Therapy

Best Publications

  • Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

    Jay S. Yadav;Mark H. Wholey;Richard E. Kuntz;Pierre B Fayad

  • Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association

    Michael R. Jaff;M. Sean McMurtry;Stephen L. Archer;Mary Cushman

  • Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006.

    P.-J. Touboul;M.G. Hennerici;S. Meairs;H. Adams

  • Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004-2006-2011). An Update on Behalf of the Advisory Board of the 3rd, 4th and 5th Watching the Risk Symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011.

    P.-J. Touboul;M.G. Hennerici;S. Meairs;H. Adams

  • 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Thom W. Rooke;Alan T. Hirsch;Sanjay Misra;Anton N. Sidawy

  • Stenting and medical therapy for atherosclerotic renal-artery stenosis

    Christopher J. Cooper;Timothy P. Murphy;Donald E. Cutlip;Kenneth Jamerson

  • American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

    Thomas L. Ortel;Ignacio Neumann;Walter Ageno;Rebecca Beyth;Rebecca Beyth

  • A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.

    Gregory Piazza;Benjamin Hohlfelder;Michael R. Jaff;Kenneth Ouriel

  • 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

    Karen A. Hicks;James E. Tcheng;Biykem Bozkurt;Bernard R. Chaitman

  • Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery Twelve-Month Results From the RESILIENT Randomized Trial

    John R. Laird;Barry T. Katzen;Dierk Scheinert;Johannes Lammer

  • Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysis

    Saurav Chatterjee;Anasua Chakraborty;Ido Weinberg;Mitul Kadakia

  • Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease 12-Month Results From the IN.PACT SFA Randomized Trial

    Gunnar Tepe;John Laird;Peter Schneider;Marianne Brodmann

  • Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis

    Suresh Vedantham;Samuel Z. Goldhaber;Jim A. Julian;Susan R. Kahn

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

    Karen A. Hicks;Kenneth W. Mahaffey;Roxana Mehran;Steven E. Nissen

  • Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results

    Michael D. Dake;Gary M. Ansel;Michael R. Jaff;Takao Ohki

  • Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

    K. Rosenfield;M.R. Jaff;C.J. White

  • Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

    Stephan H. Duda;Stephan H. Duda;Marc Bosiers;Johannes Lammer;Dierk Scheinert

  • The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients

    Jeffrey W. Olin;James Froehlich;Xiaokui Gu;J. Michael Bacharach

  • Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease Six-Month Outcomes From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study

    Timothy P. Murphy;Donald E. Cutlip;Judith G. Regensteiner;Emile R. Mohler

  • Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications.

    Krishna J. Rocha‐Singh;Thomas Zeller;Michael R. Jaff

Frequent Co-Authors

Christopher J. White
Christopher J. White University of Queensland
Thomas Zeller
Thomas Zeller University of Freiburg
Jeffrey W. Olin
Jeffrey W. Olin Icahn School of Medicine at Mount Sinai
Alan T. Hirsch
Alan T. Hirsch University of Minnesota
Joshua A. Beckman
Joshua A. Beckman Vanderbilt University Medical Center
Jeffrey J. Popma
Jeffrey J. Popma Beth Israel Deaconess Medical Center
Emile R. Mohler
Emile R. Mohler University of Pennsylvania
William R. Hiatt
William R. Hiatt University of Colorado Denver
Michael D. Dake
Michael D. Dake University of Arizona
Donald E. Cutlip
Donald E. Cutlip Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it’s important to know there are diverse online degrees and career pathways in healthcare. For those seeking advanced nursing roles, accelerated options such as a 1 year dnp program online can help you gain leadership credentials more quickly.

If your interest lies in pharmacy, pursuing online pharmacist programs provides a flexible route to becoming a doctor of pharmacy, opening doors to clinical and research positions.

For students more focused on healthcare data and administration, a health information management bachelor degree online prepares you for managing patient records, healthcare IT, and regulatory compliance.

Alternatively, you can kickstart a career in the growing medical administration sector by enrolling in billing and coding classes online. These programs teach the vital skills needed for supporting healthcare providers and ensuring smooth billing processes.

Each of these online opportunities offers unique benefits, flexible schedules, and dedicated career pathways for those passionate about healthcare—beyond clinical medicine.

Best Scientists Citing Michael R. Jaff

Trending Scientists

Recently Published Articles